American vanguard corp (AVD)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net income

520

3,436

3,153

3,106

3,906

7,403

6,490

5,564

4,605

8,399

4,018

4,531

3,413

3,854

2,841

3,382

2,947

2,917

2,704

739

-43

1,482

608

-29

2,005

102

8,745

8,266

16,819

11,272

8,076

8,744

8,734

6,431

4,618

6,007

5,012

Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization of fixed and intangible assets

4,762

4,751

4,659

4,624

4,609

4,658

4,717

4,533

4,983

4,601

4,264

4,155

3,939

3,960

4,008

4,044

4,315

4,284

4,326

3,910

3,954

4,336

4,000

4,263

3,733

3,662

3,722

3,762

3,699

3,572

2,869

3,577

3,469

3,180

3,633

3,482

3,251

Amortization of other long term assets

1,026

1,033

1,028

1,064

1,082

1,254

1,317

1,150

1,163

1,226

1,218

1,354

1,423

1,268

1,577

1,266

1,092

1,283

1,258

1,304

1,430

1,479

1,305

1,573

1,454

1,622

1,174

966

836

864

487

892

682

-35

84

681

1,253

Amortization of discounted liabilities

4

-

-

-

-

45

112

100

102

90

7

7

6

-12

9

10

9

22

-36

105

49

75

74

106

69

44

44

44

42

226

196

198

198

735

-352

600

388

Provision for bad debts

359

307

283

-589

1,034

676

359

-70

251

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revision of deferred compensation

-

-

-

-1,345

-1,543

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

1,357

2,001

2,164

1,510

1,485

1,570

1,457

1,469

1,309

1,129

1,263

1,242

1,080

1,511

588

612

456

938

458

1,058

1,427

1,107

1,240

1,038

768

924

1,148

1,059

688

1,094

825

609

422

508

455

508

523

Excess tax benefit from share based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

14

35

12

35

15

1

6

1

37

1

27

235

383

0

0

57

128

333

117

43

-

-

-

-

Decrease in deferred income taxes

-910

3,075

113

170

-742

-

-

-

-

392

-1

-1

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from equity method investment

-13

-60

-89

-36

-24

662

-533

-301

-217

177

-115

-69

-42

-44

-180

-47

-82

-

-

-

-

-350

-237

-68

-328

-

-

-

-

-

-

-

-

-

-

-

-

Net foreign currency adjustment

-823

-

-

-

-172

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from dilution of equity method investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

698

0

256

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities associated with operations:
Decrease (increase) in net receivables

5,472

-4,600

23,824

-1,029

-6,812

-2,386

30,219

-14,851

9,554

-16,495

36,495

-9,327

-11,422

-7,385

15,046

-6,046

10,202

-19,206

15,147

-5,364

-3,611

-3,524

15,970

-29,915

30,940

-36,655

42,817

-79,421

70,908

-29,010

32,653

-26,438

30,300

-27,874

21,876

11,119

29,900

Increase in inventories

16,446

-23,530

-7,922

3,872

23,763

-7,865

-889

20,636

19,558

-18,396

-3,293

4,140

1,366

-21,102

-9,424

6,687

7,938

-25,019

-3,738

-1,747

1,350

-5,889

-3,720

16,781

18,629

12,658

22

17,661

21,538

-4,864

12,893

5,255

3,599

-9,751

199

3,323

3,243

Increase in prepaid expenses and other assets

776

27

-995

-880

2,724

-1,145

252

145

562

-4,325

1,020

1,532

1,126

2,861

-1,650

1,625

1,036

-939

-1,000

-1,444

1,301

-494

188

1,807

3,242

5,169

4,727

2,810

7,027

14,863

6,307

987

1,568

938

-906

-197

1,988

Decrease (increase) in income tax receivable/payable, net

-597

-2,378

3

-5,230

750

586

2,340

226

-497

64

615

-13,545

793

-333

275

39

1,205

133

5,617

-500

-378

-3,513

7,817

-575

695

-

-

-

6,108

1,493

251

-3,332

3,725

-2,634

1,013

0

8,133

(Decrease) increase in accounts payable

-189

-2,461

4,622

-14,926

4,788

3,386

-5,598

1,696

9,613

-1,234

3,977

3,604

-3,025

1,090

-1,912

-3,194

13,031

-8,078

3,402

-3,962

3,570

2,390

-5,820

-16,140

-381

7,840

8,944

-39,782

31,250

1,038

8,075

-520

1,188

442

-1,147

1,386

7,703

Decrease in deferred revenue

-2,342

6,445

-362

-3,402

-16,036

19,433

-6,711

-4,514

-2,740

14,574

-1,722

-1,732

-394

3,807

-6,915

-84

-1,848

8,850

-4,471

-49

3,660

-121

-493

33

-2,309

3,395

115

-2,001

-18,148

19,126

1,100

201

-7,571

7,560

-83

59

-5,533

Increase in accrued program costs

6,016

-14,366

8,340

9,432

2,391

-24,587

7,843

10,405

4,634

-27,249

3,901

12,207

6,612

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other payables and accrued expenses

-2,094

1,599

1,783

-4,211

-2,508

2,418

1,891

-482

-3,201

-279

694

1,401

-5,657

1,533

1,486

-5,900

7,512

337

821

-4,420

5,214

-20,661

-300

11,214

5,050

-42,130

9,559

14,429

40,100

-29,359

6,740

13,818

17,065

-20,424

12,756

14,324

3,896

Net cash used in by operating activities

-13,946

31,087

10,402

-11,823

-20,263

26,436

-18,809

12,954

-9,235

40,757

-15,873

16,947

17,170

10,206

10,710

15,900

9,590

26,761

7,983

23,982

19,842

-259

-4,797

12,851

-41,890

-13,414

-12,845

38,181

-18,136

27,323

-23,567

44,266

-7,598

37,161

-192

12,802

-10,505

Cash flows from investing activities:
Capital expenditures

2,980

2,439

3,330

3,847

3,369

2,896

1,924

1,677

1,553

1,333

1,178

1,075

3,080

4,508

4,393

1,014

715

1,703

1,716

1,958

1,522

1,233

1,993

2,138

1,816

2,970

3,930

3,964

4,396

2,720

1,847

7,343

5,718

1,795

2,144

1,412

910

Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,283

-

-

-

-

-

-

-

-

0

0

0

3,687

-

-

-

-

-

-

-

-

Acquisitions of businesses, product lines and intangible assets

-

10,016

7,534

56

24,246

18,013

3

816

815

55,992

12,504

13,100

300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-2,980

-12,455

-10,864

-3,903

-27,615

-20,909

-1,927

-2,493

-2,368

-57,325

-13,682

-15,125

-3,380

-4,508

-4,393

-1,238

-3,998

-1,935

-1,716

-38,518

-1,522

-1,733

-1,993

-2,138

-1,816

-2,970

-3,930

-3,964

-8,083

-6,193

-1,847

-7,343

-5,718

-2,111

-2,144

-1,412

-910

Cash flows from financing activities:
Net borrowings under line of credit agreement

19,400

-16,300

122,400

-106,800

52,600

-700

81,800

-39,125

-23,000

96,050

0

-32,025

-27,000

-83,600

21,850

-31,250

-14,600

-105,280

-5,000

3,280

-14,400

1,150

9,020

-13,020

47,450

12,800

-2,000

34,550

6,200

-

-

-

-

0

0

0

-7,300

Borrowings under line of credit agreement

-

-

-

-

-

-

-

23,000

35,800

-

31,000

29,000

16,000

-

-

15,000

12,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

20,063

Increase in other notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

9,800

200

-

-

-

-

0

0

0

-6,154

6,409

367

-792

-6,035

-

-

-

-

Payments on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

43,500

2,500

2,443

2,000

2,000

2,000

1,600

2,825

2,000

2,004

Payment on other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

163

84

84

373

291

353

548

351

385

262

753

356

416

177

556

682

-

-

-

-

-

-

-

-

Excess tax benefit from share based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

14

35

12

35

15

1

6

1

37

1

27

235

383

0

0

57

128

333

117

43

-

-

-

-

Net payments from the issuance of common stock (sale of stock under ESPP, exercise of stock options, and shares purchased for tax withholdings)

-2,177

313

483

37

-550

-14

396

525

810

107

394

-1,517

303

37

399

120

-315

63

294

925

-965

50

420

178

1,018

681

402

100

427

-33

1,975

868

417

6

24

0

550

Repurchase of common stock

-

0

0

0

2,604

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,531

-

-

-

-

-

-

-

-

-

-

-

-

Payment of cash dividends

582

582

581

579

581

588

587

586

438

439

437

435

289

-

-

-

-

0

0

572

569

1,421

1,415

1,418

1,418

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

16,641

-17,419

302

14,658

48,865

-8,662

22,809

-16,186

13,172

18,967

30,957

-5,003

-10,986

-4,001

-5,089

-16,202

-3,253

-24,613

-5,058

12,891

-16,084

2,680

8,064

-14,986

45,398

10,100

-3,189

-11,382

-2,652

-6,342

675

-3,187

-7,575

-3,374

-2,801

-2,826

11,309

Net (decrease) increase in cash and cash equivalents

-285

1,213

-160

-1,068

987

-3,135

2,073

-5,725

1,569

2,399

1,402

-3,181

2,804

1,697

1,228

-1,540

2,339

213

1,209

-1,645

2,236

688

1,274

-4,273

1,692

-6,284

-19,964

22,835

-28,871

14,788

-24,739

33,736

-20,891

31,676

-5,137

8,564

-106

Effect of exchange rate changes on cash and cash equivalents

-752

-519

-260

718

-498

-65

196

-194

112

-107

46

-14

119

-422

-433

-577

53

-118

-869

-136

-251

-848

-418

71

19

639

-125

-416

390

64

315

-420

538

-423

-989

120

222

Non-cash investing activities:
Deferred consideration in connection with business acquisitions:

-

-

-

-

2,645

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-